Skip to main content

Advertisement

Fig. 3 | BMC Systems Biology

Fig. 3

From: Escherichia coli B2 strains prevalent in inflammatory bowel disease patients have distinct metabolic capabilities that enable colonization of intestinal mucosa

Fig. 3

Simulated growth capabilities of 107 GEMs on various nutrient sources. a 107 strains are clustered by simulated growth capabilities on 143 differentiating nutrient sources. b Simulated growth on monosaccharides and their derivatives from mucus glycan. c Simulated growth on butyrate, fructoselysine and psicoselysine

Back to article page